Miami, July 01, 2024 (GLOBE NEWSWIRE) -- Miami, FL – July 1st , 2024. Aleph Group, the global leader in connecting leading global digital media platforms with advertisers and consumers in primari...…[详细]
丁六五,1965年生,号;陇上十千,甘肃省羲皇故里天水人。现为中华人民共和国文化部高级画家,人民画院美术家,“一带一路大型活动组委会书画专业委员会会员,中国 红色收藏家协会书画顾问。 ...…[详细]
- Program open to Schneider Electric customers, channel partners, and suppliers worldwide - Application process has been simplified, and continues to focus on how applicants achieve results via strat...…[详细]
- Program open to Schneider Electric customers, channel partners, and suppliers worldwide - Application process has been simplified, and continues to focus on how applicants achieve results via strat...…[详细]
- Program open to Schneider Electric customers, channel partners, and suppliers worldwide - Application process has been simplified, and continues to focus on how applicants achieve results via strat...…[详细]
Sportradar's Managed Trading Services See Significant Global Adoption in H1 2024 Notable client wins in South America and Africa highlight growth ST. GALLEN, Switzerland, July 01, 2024 (GLOBE NEWS...…[详细]
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- CertiK, Web3’s leading blockchain security company, announced today that CertiK has successfully migrated its cloud infrastructure in Asia to Alibaba Cloud...…[详细]
纽约, July 01, 2024 (GLOBE NEWSWIRE) -- 头部Web3.0安全公司CertiK宣布已顺利完成其亚洲区域云基础设施向阿里云的迁移。这一战略举措通过阿里云先进的资源管理服务,以增强CertiK区块链应用的安全性、稳定性和成本...…[详细]
中国禅意书画家王殿怀(传心居士)简介: 王殿怀,字础恒,号传心居士,無跡堂主,毕业于清华美院。1968年生人,祖籍河北。以丹青墨宝弘扬禅法,用出世心态度化世人。其禅书禅画、水墨人物、山水、题画书语...…[详细]
VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Bedford Metals Corp. (TSX-V: BFM) (the “Company” or “Bedford”) is pleased to announce the successful completion and assessment of...…[详细]
Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovativ...…[详细]
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US Pyzchiva® (ustekinumab-ttwe)...…[详细]